Digital health is a core focus for Philips. Might more acquisitions be on the way?
Cynosure’s technology seems to have been better at destroying value than it was at destroying fat – Hologic has sold the business for a tenth of the purchase price.
The Japanese company is to hand across $3bn to Roivant for various subsidiaries that hold an eclectic portfolio of assets.
Planned divestment of Celgene’s psoriasis blockbuster means instant cashback for Bristol, a result the markets see as a win-win-win.
GE sells its Biopharma business for $21.4bn, but is its IPO cancelled or merely on hold?